| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.
|
J Clin Oncol
|
2011
|
3.10
|
|
2
|
Gain-of-function mutations and copy number increases of Notch2 in diffuse large B-cell lymphoma.
|
Cancer Sci
|
2009
|
1.95
|
|
3
|
Hepatic toxicity and prognosis in hepatitis C virus-infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis.
|
Blood
|
2010
|
1.91
|
|
4
|
Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia.
|
Cancer Sci
|
2008
|
1.75
|
|
5
|
The role of hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma.
|
Am J Hematol
|
2014
|
1.40
|
|
6
|
Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal type.
|
Blood
|
2011
|
1.17
|
|
7
|
The corepressor mSin3A regulates phosphorylation-induced activation, intranuclear location, and stability of AML1.
|
Mol Cell Biol
|
2004
|
1.16
|
|
8
|
Serum autotaxin measurement in haematological malignancies: a promising marker for follicular lymphoma.
|
Br J Haematol
|
2008
|
1.13
|
|
9
|
Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type.
|
Clin Cancer Res
|
2012
|
1.06
|
|
10
|
Clinical features of late cytomegalovirus infection after hematopoietic stem cell transplantation.
|
Int J Hematol
|
2008
|
1.01
|
|
11
|
Oligomerization of Evi-1 regulated by the PR domain contributes to recruitment of corepressor CtBP.
|
Oncogene
|
2005
|
1.00
|
|
12
|
AML1 is functionally regulated through p300-mediated acetylation on specific lysine residues.
|
J Biol Chem
|
2004
|
1.00
|
|
13
|
Myeloablative allogeneic hematopoietic stem cell transplantation for non-Hodgkin lymphoma: a nationwide survey in Japan.
|
Blood
|
2006
|
0.98
|
|
14
|
Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.
|
Am J Hematol
|
2008
|
0.94
|
|
15
|
Successful sustained engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with severe aplastic anemia.
|
Blood
|
2011
|
0.92
|
|
16
|
In vivo alemtuzumab enables haploidentical human leukocyte antigen-mismatched hematopoietic stem-cell transplantation without ex vivo graft manipulation.
|
Transplantation
|
2005
|
0.90
|
|
17
|
The origin of neoplastic mast cells in systemic mastocytosis with AML1/ETO-positive acute myeloid leukemia.
|
Exp Hematol
|
2007
|
0.89
|
|
18
|
Mycophenolate and tacrolimus for graft-versus-host disease prophylaxis for elderly after cord blood transplantation: a matched pair comparison with tacrolimus alone.
|
Transplantation
|
2011
|
0.88
|
|
19
|
Intensive chemotherapy for elderly patients with acute myelogeneous leukemia: a propensity score analysis by the Japan Hematology and Oncology Clinical Study Group (J-HOCS).
|
Ann Hematol
|
2012
|
0.86
|
|
20
|
Decreased incidence of acute graft-versus-host disease by continuous infusion of cyclosporine with a higher target blood level.
|
Am J Hematol
|
2008
|
0.86
|
|
21
|
Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation.
|
Am J Hematol
|
2007
|
0.85
|
|
22
|
Early relapse of JAK2 V617F-positive chronic neutrophilic leukemia with central nervous system infiltration after unrelated bone marrow transplantation.
|
Am J Hematol
|
2007
|
0.85
|
|
23
|
False-positive Aspergillus galactomannan antigenaemia after haematopoietic stem cell transplantation.
|
J Antimicrob Chemother
|
2007
|
0.84
|
|
24
|
Presumptive treatment strategy for aspergillosis in allogeneic haematopoietic stem cell transplant recipients.
|
J Antimicrob Chemother
|
2007
|
0.83
|
|
25
|
Guidelines for the management of cutaneous lymphomas (2011): a consensus statement by the Japanese Skin Cancer Society - Lymphoma Study Group.
|
J Dermatol
|
2012
|
0.82
|
|
26
|
A case of adult Langerhans cell histiocytosis showing successfully regenerated osseous tissue of the skull after chemotherapy.
|
Int J Hematol
|
2008
|
0.81
|
|
27
|
Conventional allogeneic hematopoietic stem cell transplantation for lymphoma may overcome the poor prognosis associated with a positive FDG-PET scan before transplantation.
|
Am J Hematol
|
2008
|
0.80
|
|
28
|
CD8+ memory T cells predominate over naïve T cells in therapy-free CML patients with sustained major molecular response.
|
Leuk Res
|
2009
|
0.79
|
|
29
|
Possible association of trisomy 8 with secondary pulmonary alveolar proteinosis in myelodysplastic syndrome.
|
Am J Respir Crit Care Med
|
2011
|
0.78
|
|
30
|
Prednisone versus high-dose dexamethasone for untreated primary immune thrombocytopenia. A retrospective study of the Japan Hematology & Oncology Clinical Study Group.
|
J Thromb Thrombolysis
|
2014
|
0.78
|
|
31
|
[Herpes simplex virus type 2 fulminant hepatitis after umbilical cord blood transplantation for acute myeloid leukemia].
|
Rinsho Ketsueki
|
2014
|
0.78
|
|
32
|
Durable remission after the administration of rituximab for EBV-negative, diffuse large B-cell lymphoma following autologous peripheral blood stem cell transplantation for angioimmunoblastic T-cell lymphoma.
|
Leuk Lymphoma
|
2007
|
0.78
|
|
33
|
Prognostic significance of CD20 expression and Epstein-Barr virus (EBV) association in classical Hodgkin lymphoma in Japan: a clinicopathologic study.
|
Pathol Int
|
2014
|
0.78
|
|
34
|
Autologous stem cell transplantation with PCR-negative graft would be associated with a favorable outcome in core-binding factor acute myeloid leukemia.
|
Biol Blood Marrow Transplant
|
2008
|
0.78
|
|
35
|
A prospective feasibility study of primary prophylaxis against invasive fungal disease with voriconazole following umbilical cord blood transplantation with fludarabine-based conditioning.
|
Int J Hematol
|
2014
|
0.76
|
|
36
|
A case report of the histologic transformation of primary follicular lymphoma of the duodenum.
|
Medicine (Baltimore)
|
2014
|
0.75
|
|
37
|
Cytotoxic molecule-positive classical Hodgkin's lymphoma: a clinicopathological comparison with cytotoxic molecule-positive peripheral T-cell lymphoma of not otherwise specified type.
|
Haematologica
|
2011
|
0.75
|
|
38
|
Pharmacokinetics of alemtuzumab after haploidentical HLA-mismatched hematopoietic stem cell transplantation using in vivo alemtuzumab with or without CD52-positive malignancies.
|
Am J Hematol
|
2006
|
0.75
|
|
39
|
[Hematologic Malignancies/Pediatric Malignancies. IV. Progress in the Management of Mantle Cell Lymphoma].
|
Gan To Kagaku Ryoho
|
2016
|
0.75
|
|
40
|
Intravascular large B-cell lymphoma with symptoms resembling progressive dementia: a clinical case report.
|
J Am Geriatr Soc
|
2013
|
0.75
|
|
41
|
Sporadic late-onset nemaline myopathy as a rare cause of slowly progressive muscle weakness with young adult onset.
|
Muscle Nerve
|
2015
|
0.75
|
|
42
|
[Recommendation for the optimal use of bendamustine in Japan].
|
Rinsho Ketsueki
|
2014
|
0.75
|
|
43
|
[Subacute encephalopathy after high-dose methotrexate as prophylaxis for central nervous system relapse in a patient with intravascular large B-cell lymphoma].
|
Rinsho Ketsueki
|
2015
|
0.75
|
|
44
|
Simultaneous appearance of methotrexate-associated lymphoproliferative disorder and tuberculous meningitis demonstrating the definitive role of immunosuppression.
|
Ann Hematol
|
2008
|
0.75
|
|
45
|
Cunninghamella bertholletiae pneumonia showing a reversed halo sign on chest computed tomography scan following cord blood transplantation.
|
Med Mycol
|
2011
|
0.75
|
|
46
|
Diabetes mellitus is associated with high early-mortality and poor prognosis in patients with autoimmune hemolytic anemia.
|
Hematology
|
2009
|
0.75
|
|
47
|
Primary cutaneous anaplastic large cell lymphoma with leg involvement: a case report and review of 11 cases.
|
J Dermatol
|
2011
|
0.75
|
|
48
|
[Management of follicular lymphoma].
|
Rinsho Ketsueki
|
2014
|
0.75
|
|
49
|
[Malignant lymphoma. Current topics. 1. Antibody therapy].
|
Nihon Naika Gakkai Zasshi
|
2008
|
0.75
|
|
50
|
[Angioimmunoblastic T-cell lymphoma].
|
Nihon Rinsho
|
2014
|
0.75
|
|
51
|
Mutational analyses of the AML1 gene in patients with myelodysplastic syndrome.
|
Leuk Lymphoma
|
2002
|
0.75
|
|
52
|
[Recent advances in the management of follicular lymphoma].
|
Rinsho Ketsueki
|
2011
|
0.75
|
|
53
|
Should young patients with e19a2 type BCR/ABL rearrangement undergo stem cell transplantation?
|
Leuk Lymphoma
|
2003
|
0.75
|
|
54
|
Late-onset pneumatosis cystoides intestinalis associated with non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation.
|
Int J Hematol
|
2008
|
0.75
|
|
55
|
Elevated serum levels of soluble interleukin-2 receptor in chronic eosinophilic leukemia/hypereosinophilic syndrome with FIP1L1-PDGFR alpha fusion gene.
|
Int J Hematol
|
2008
|
0.75
|
|
56
|
Treatment results of chemoradiation therapy for localized aggressive lymphomas: A retrospective 20-year study.
|
Ann Hematol
|
2006
|
0.75
|
|
57
|
Rapid T-cell chimerism switch and memory T-cell expansion are associated with pre-engraftment immune reaction early after cord blood transplantation.
|
Br J Haematol
|
2012
|
0.75
|
|
58
|
[Immunosuppressive therapy with antithymocyte globulin and cyclosporine for paroxysmal nocturnal hemoglobinuria].
|
Rinsho Ketsueki
|
2008
|
0.75
|